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Abstract In order to localize the active site of the vitamin 
K-dependent carboxylase, we developed an affinity probe 
containing the propeptide and the first two carboxylatable 
glutamate residues conserved in many native substrates. This 
probe crosslinked to both the hydrophobic amino-terminal and 
hydrophilic carboxy-terminal domains of the carboxylase, in 
contrast with previous work which localized both the catalytic 
and the propeptide binding site within the amino-terminal 
hydrophobic domain. Amino acid analysis revealed that the mass 
of an amino-terminal fragment is seriously underestimated by 
SDS-PAGE. Reanalysis of the published data in light of this 
information suggests that a portion of the propeptide binding site 
resides within the carboxy-terminal hydrophilic domain. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The y-glutamyl carboxylase is involved in the post-transla-
tional maturation process of vitamin K-dependent proteins 
such as blood clotting factors (Factors VII, FIX, FX and 
prothrombin), anti-clotting factors (proteins C and S), bone 
gla protein, bone matrix protein, protein Z and others [1-5]. 
During this maturation process, the y-glutamyl carboxylase 
adds a second carboxyl group to selected glutamate residues 
localized near the amino terminus of those proteins. In the 
case of clotting factors, a propeptide region (—18 to —1) is a 
crucial element in substrate recognition by the y-glutamyl car-
boxylase [6-8]. 
The y-glutamyl carboxylase is a glycosylated membrane 
protein that has been purified to near homogeneity from bo-
vine liver endoplasmic reticulum [9]. The first complete y-glu-
tamyl carboxylase sequence (758 amino acids) was deduced 
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from the human cDNA [10] and the protein has been ex-
pressed with activity in several cell types [10-12]. The enzyme 
probably has 3 or 5 transmembrane spans in the hydrophobic 
amino-terminal part of the protein. 
In order to determine the contributions of the hydrophobic 
and hydrophilic domains to the active site and substrate bind-
ing site, synthetic peptide probes designed to mimic the natu-
ral substrates have been crosslinked to the carboxylase. Using 
the affinity peptide-substrate inactivator, [125I]tyrosyl-Ar-(bro-
moacetyl)-FLEELY, Kuliopulos et al. labeled a site in the 
amino-terminal part of the carboxylase [17] suggesting that 
the catalytic active site could reside in the amino-terminal 
hydrophobic domain of the enzyme. In order to identify the 
propeptide binding site Yamada et al. used [125I]tyrosyl-
proFIX19 analogs containing the photoactivatable residue, 
jP-benzoylphenylalanine (Bpa) and labeled sites that were 
also localized in the amino-terminal hydrophobic part of the 
carboxylase [18]. This later result was confusing since bifunc-
tional crosslinking reagents had crosslinked a propeptide 
probe to the carboxy-terminal hydrophilic domain [19,20]. 
Having contributed to the understanding of the catalytic 
mechanism [13-16], we are now turning to study the protein. 
In the present study we used a photactivatable affinity probe 
containing the factor IX propeptide sequence (—18 to — 1) 
and a portion of prothrombin (+1 to +10) [21] to label the 
carboxylase (CP1, Table 1). The photoactivatable group, Bpa 
[22], was placed at position +4 close to the first carboxylatable 
glutamate residue (+6) in order to identify the catalytic active 
site of the carboxylase. An iodinated version of this probe, 
[125I]CP2, labeled both an amino-terminal 30-kDaapp trypsin 
fragment containing the hydrophobic domain and a carboxy-
terminal 60-kDaapl, trypsin fragment containing the hydro-
philic domain, suggesting that the active site region includes 
portions of both domains. Moreover, purification and amino 
acid analysis of the 60-kDaapp fragment surprisingly indicated 
its mass was seriously underestimated by SDS-PAGE. 
In previous studies [17,18] crosslinking sites were localized 
indirectly using fragment molecular mass estimation based on 
SDS-PAGE mobility. In light of this new information we 
reinterpreted the published data to obtain an internally con-
sistent picture that suggests that a significant portion of the 
propeptide binding site is in the carboxy-terminal hydrophilic 
domain. 
2. Materials and methods 
2.1. Synthesis, purification and iodination of Bpa peptides 
Solvents and reagents were used without further purification, except 
for triethylamine and trifluoroacetic acid which were distilled. The 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(97)00831-4 
2 M. Maillet et al.lFEBS Letters 413 (1997) 1-6 
NaBoc amino acids were purchased from Bachem, Neosystem, No-
vabiochem and Propeptide. The NaBoc Bpa was prepared2 with an 
overall yield of 61%. Peptides (FLEEV, proFIX/PT28, CP1, CP2 and 
proFIX19) were prepared by the solid phase procedure with NaBoc 
amino acids using a ABI 431A synthesizer [25], with 0.1 mmol of 
PMA resin. The deprotected peptides were purified by RP-HPLC 
(purity superior to 95%). The molecular mass of the peptides was 
confirmed with mass spectrometry, by B. Renaud and J-C. Tabet 
(Universite Pierre et Marie Curie). The X^ iax and e (M _ 1 cm - 1) 
were 264 nm and 11460 nm for CP1 and 264 nm and 16140 nm 
for [127I]CP2. 
The tyrosyl residue of CP2 (1.41 umol) was iodinated with Na127I 
(800 ill, 2.65 nM in 0.1 N NaOH) in a sodium acetate buffer (3 ml, 
0.5 N, pH = 6) by addition of a chloramin T solution (235 ul, 9 mM) 
[26], The reaction was stopped after 5 min by addition of a sodium 
thiosulfate solution (500 ul, 1.48 mg/ml). The 100% monoiodinated 
peptide was purified by RP-HPLC and the molecular mass confirmed 
with mass spectrometry (MALDI-TOF) by B. Renaud (Universite 
Pierre et Marie Curie). The 125I iodination of CP2 was performed 
using iodo-beads according to manufacture instructions (Biorad). 
The specific activity of [125I]CP2 was 184 Ci/mole. 
2.2. Carboxylase purification, assay and analysis 
Carboxylase was prepared from bovine liver using a proFIXQ/S 
affinity matrix as described [9,27], The purified enzyme preparation 
used in this study contained between 4 and 30 nM carboxylase, 1.6 uM 
ProFIX19, 0.8% CHAPS, 0.1% PC, 25 mM MOPS (pH 7.4), 500 mM 
NaCl and 20% glycerol. 
Incorporation of 14CC"2 into peptide substrates was measured in 
125 (Xl reactions containing 56 ul of Buffer A (25 mM MOPS pH 7, 
100 mM NaCl, 20% glycerol), peptide (20 ul), PC/CHAPS (4 JJLI, 5%/ 
5%), ammonium sulfate (25 ul, 4 M), carboxylase (20 ul, 20 nM), 
Vitamin K hydroquinone (5 ul, 10.8 mM, 162 mM DTT) and 
NaH1 4C03 (5 ul, 5 uCi). The reaction was started by the addition 
of NaH1 4C03 at 20°C and stopped after 30 min by the addition of 
50 ul of 30% TCA. Aliquots of 100 ul were then placed into a desic-
cator containing P2O5 and KOH overnight. Samples were taken up 
into 300 ul of water and 1 ml of Aquasol scintillation fluid and 
counted on a LKB 1214 Rack-beta liquid scintillation counter. 
The carboxylase and the carboxylase fragments were analyzed on 
mini gels [28] which included a 4% stacking gel and a resolving gel 
with the acrylamide concentration indicated in the text. Following 
electrophoresis, gels were phosphoimaged immediately without fixing 
or drying. 
2.3. Photolabeling of y-glutamyl carboxylase with Bpa peptides 
Prior to photoinactivation of the carboxylase with the Bpa peptides, 
the same volumes of Buffer A, carboxylase, PC/CHAPS and ammo-
nium sulfate as used in the carboxylase assay were combined with Bpa 
peptides (5 ul, 150 uM) (total volume 100 ul) and preincubated for 
30 min at 20°C. Samples in Eppendorf tubes were then placed in an 
ice bath and irradiated at 6 cm from a Phillips HPR 125 UV lamp for 
various times. Following irradiation each 100 ul reaction point re-
ceived FLEEV (15 ul, 30 mM), Vitamin K hydroquinone (5 ul, 
10.8 mM, 162 mM DTT) and NaH14COs (5 ul, 5 uCi). The carbox-
ylation reaction was otherwise performed according to the standard 
assay. 
For [126I]CP2 labeling of purified carboxylase, the carboxylase was 
combined with 0.02 vol of 10% PC and 0.1 vol of [125I]CP2 (6.5 uM 
except otherwise indicated). Samples were incubated for 30 min at 
20°C prior to photoirradiation for 15 min in an ice bath as described 
above. Following irradiation, samples to be subjected to SDS-PAGE 
were combined with 4 X SDS-PAGE sample buffer containing 40 mM 
DTT and run on 10% gels. Relative radioactivity incorporated into 
the carboxylase under various conditions was quantitated from the 
phosphoimage on a Molecular Dynamics Phosphoimager (Sunnyvale, 
CA). In some cases the incorporated radioactivity was determined 
directly by gamma counting. In competition experiments with pro-
FIX/PT28, 0.2 vol of this peptide at various concentrations was added 
just prior to 0.1 vol of [125I]CP2 (55 nM). 
2.4. Proteolytic analysis of [125I]CP2-labeled carboxylase 
Labeled carboxylase was incubated with 0.03 vol of Trypsin (1.8 ng/ 
2 Using p-bromomethyl benzophenone according to [23,24]. 
ul) at 0°C for 1 h. For samples subjected to SDS-PAGE the reaction 
was terminated by addition of 2 X sample buffer with 20 mM DTT. 
Large scale trypsin cleavage of [125I]CP2-labeled carboxylase (60 ml, 
30 nM) was performed in the same way except the trypsin reaction 
was terminated by the addition of 0.02 vol of 500 ug/ul Leupeptin. 
Aliquots of these digestions were frozen in liquid nitrogen and stored 
at -70°C. 
To purify the 30 and 60-kDaapp trypsin fragments, portions (10 ml) 
of labeled trypsinized carboxylase ( ~ 300 pmol) were thawed, com-
bined with 1 ml of 10% SDS and loaded onto a 140 ml Sephacryl 300 
column equilibrated with column buffer (20 mM MOPS, pH 7 and 
0.1% SDS). The column was eluted with column buffer at room tem-
perature. Fractions (2 ml) containing the labeled carboxylase (20 ml) 
were combined and concentrated using two Centriplus 3 concentrators 
(Amicon) at room temperature by overnight centrifugation at 
3000 Xg. SDS-PAGE sample buffer which did not contain DTT was 
added to the concentrated carboxylase (100 to 500 ul) and this mate-
rial was run on 10% gels. The labeled carboxylase was located on the 
gel and then cut out using both a phosphoimage of the unfixed gel 
and prestained markers. Gel slices containing the carboxylase were 
combined with an equal volume of 2 X SDS-PAGE sample buffer con-
taining 200 mM DTT and incubated for 2 h at room temperature. 
These slices and the equilibrated buffer were then placed onto a sec-
ond gel which included a stacking gel twice the depth of the sample 
wells. Following electrophoresis gel slices containing separately the 
reduced 30 and 60-kDaapp trypsin fragments were cut out as described 
previously. The fragments were sometimes combined with elution 
buffer (20 mM MOPS, pH 7.4, 0.1% SDS) and eluted into dialysis 
tubing (12 kDa cutoff) in elution buffer with 10 V/cm electric field for 
1.5 h. Alternatively the fragments were digested 'in gel' as described 
below. During all these purification steps the recovery was estimated 
by gamma counting of the incorporated 125I. 
For 'in gel' digestions, gel slices containing, respectively, the 30 and 
60-kDaapp fragments were frozen in liquid nitrogen and stored at 
—70°C. Immediately before use these slices were thawed, combined 
with 2 X SDS-PAGE sample buffer containing 20 mM DTT and in-
cubated for 60 min at room temperature. The slices were then placed 
at the bottom of stacking gel wells which were half as deep as the 
stacking gel. Protease was added to the equilibrating sample buffer 
and this was layered over the gel slice. The gel was run until the 
stacking front was 66% through the stacking gel at which time the 
power was shut off for 30 min After this digest incubation the samples 
were run through a 15% gel. 
To obtain sequence information on the purified 60-kDaapp frag-
ment, the purified fragment was run on a 10% SDS acrylamide gel 
and transferred for 90 min at 70 V to PVDF Immobilon (Millipore) as 
recommended by Millipore. Sequence was determined with an Ap-
plied Biosystems 475A Protein Sequencer by Dr. Russel Henry at 
the Protein Chemistry Laboratory at UNC Chapel Hill/NIEHS. 
3. Results 
3.1. CP1 as a substrate 
A hybrid peptide containing the propeptide sequence of 
Factor IX and the first 10 amino acids of prothrombin (pro-
FIX7PT28), was chosen as the basis of our affinity probe 
because it is a carboxylase substrate with a low Km [21]. We 
incorporated the photoprobe, Bpa, at position +4 near the 
Table 1 
Peptides sequence 
Peptide Sequence 
- 1 8 - 1 6 +1 +4 +10 
proFIX 19 TVFLDHENANKILNRPKRY 
proFIX/PT28 TVFLDHENANKILNRPKRANTFLEEVRK 
CP1 (carboxylase TVFLDHENANKILNRPKRANTBLEEVRK 
probe 1) 
CP2 (carboxylase TVFLDHENANKILNRPKRYNTBLEEVRK 
probe 2) 
B, Bpa. 
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Fig. 1. Semi-logarithmic representation of the residual carboxylase 
activity versus UV irradiation time in the presence of the Bpa pepti-
des. Carboxylase (0.4 pmol) was irradiated on ice without peptide 
inactivator ( A ) or with 7.5 uM CP1 (•), CP2 (o), or [127I]CP2 (■). 
Residual carboxylase activity was assayed by measuring 14CC>2 in-
corporation into FLEEV as described in the Methods (see Section 
2). 
carboxylatable glutamates (+6 and +7) in order to identify 
residues near the catalytic active site of the carboxylase (Table 
1). Under the assay conditions used, we found for this modi-
fied peptide, CP1 (carboxylase probe 1), had Kmt9V and VmAW 
values of 6.8 uM and 9.25 XlO6 cpm h - 1 mg_ 1, respectively. 
These values were similar to those of proFIX/PT28 (1.2 jjJVI; 
22.07XlO6 cpm h _ 1 mg_1). Thus the presence of the Bpa 
photoprobe at position +4 does not prevent association of 
CP1 with either the propeptide or glutamate binding sites in 
the carboxylase. 
3.2. Pseudo-first order inactivation of the y-glutamyl 
carboxylase by CP1, CP2 and [mI]CP2 
In order to follow the crosslinked photoaffinity ligand dur-
ing proteolytic digestion of the carboxylase, an iodination site 
was introduced into CP1 by changing the alanine at position 
+1 to tyrosine to obtain carboxylase probe 2 (CP2). To dem-
onstrate inactivation of the carboxylase by the photoaffinity 
ligands, the enzyme was photoirradiated on ice at 365 nm 
with CP1, CP2 and mono [127I]CP2 for various times. The 
remaining carboxylase activity after photoirradiation was de-
termined by measuring the incorporation of 14CC>2 into the 
pentapeptide FLEEV (3 mM) [29]. A 15 min irradiation in the 
absence of peptide resulted in a 10% inactivation of the car-
boxylase, whereas in the presence of proFIX/PT28 (Bpa +4) 
and CP2 or its iodinated derivative 56% and 80%o inactivation 
were, respectively, observed (Fig. 1). For all three peptides, 
the semi-logarithmic representation of the residual activity 
versus UV irradiation time was linear, demonstrating a pseu-
do-first order inactivation of the y-glutamyl carboxylase by an 
irreversible process. 
3.3. [125IJCP2 labeling of the y-glutamyl carboxylase 
Irradiation of the y-glutamyl carboxylase in the presence of 
[125I]CP2 resulted in incorporation of 125I into a band corre-
sponding to the purified carboxylase on SDS polyacrylamide 
gel (data not shown). Photolabeling at several probe concen-
trations (Fig. 2) showed saturation behaviour with near max-
imal labeling at a concentration of 1 uM for a 15 min irradi-
ation. In agreement with the nearly complete inactivation of 
the carboxylase under these conditions, quantitation of the 
incorporated label indicated a labeling efficiency around 90%. 
In order to demonstrate that [125I]CP2 was specifically as-
sociating with the active site region of the y-glutamyl carbox-
ylase, photocrosslinking was carried out in presence of in-
creasing concentration of proFIX/PT28. As shown in Fig. 3, 
proFIX/PT28 at concentrations above 10 uJVI prevented most 
[125I]CP2 crosslinking. 
3.4. Proteolytic digestion of the [125I]CP2-labeled carboxylase 
Limited tryptic digestion of the carboxylase yielded two 
disulfide-linked fragments with molecular masses of 30 and 
60 kDaapp, corresponding, respectively, to the amino and car-
boxy-terminal part of the y-glutamyl carboxylase (see below). 
Limited tryptic digestion of [125I]CP2-labeled carboxylase re-
vealed radioactive labeling of both the 30 and 60-kDaapp 
bands (Fig. 4). About 60%o of the total labeling were found 
in the amino-terminal 30-kDaapp fragment, while the remain-
s' 
CQ 
0.75 
0.25 
[125I-CP2](uM) 
Fig. 2. Carboxylase labeling as a function of [125I]CP2 concentra-
tion. Carboxylase was irradiated for 15 min on ice with various 
concentration of [125I]CP2 (2.6, 7.8, 70, 211, 634, 1900 and 5700 nM) 
as described in the Methods (see Section 2). Following photoirradia-
tion, aliquots (40 j_il containing 0.11 pmol of carboxylase) were run 
on a 10%> gel and imaged with a phosphoimager. Quantitation of 
the relative [125I]CP2 incorporation by phosphoimage analysis shows 
the saturable nature of this labeling. 
CQ 
J I I L J I 
0 10 20 30 40 50 60 70 
[proFIX/PT28] (uM) 
Fig. 3. ProFIX/PT28 blocks incorporation of [125I]CP2 into the car-
boxylase. Carboxylase was irradiated for 15 min on ice with 
[125I]CP2 (55 nM) and various concentrations of proFIX/PT28 
(0.26, 0.78, 2.35, 7.5, 21.16 and 63.5 uM) as described in the Meth-
ods (see Section 2). Samples (46 ul containing 0.090 pmol of car-
boxylase) were run on a 10% gel. Relative incorporation of 
[125I]CP2 into the carboxylase at the various proFIX/PT28 concen-
trations was quantitated from the phosphoimage of the gel. 
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Fig. 4. [125I]CP2 crosslinks to both the 30 and 60-kDaapp trypsin fragments. Carboxylase (18 nM) crosslinked to [
126I]CP2 was subjected to lim-
ited trypsin (2 ng/u.1) digestion for 1 h at 0°C. Following addition 2X sample buffer with 20 mM DTT, samples (50 ul) of crosslinked (lane 1) 
and crosslinked trypsinized (lane 2) carboxylase were run on 10% gel and phosphoimaged. Purified labeled 30 and 60-kDaapp trypsin fragments 
are shown in lanes 3 and 4, respectively. Fragments crosslinked to [125I]CP2 ran 5 kDa higher than uncrosslinked fragments. 
ing 40% were found in the carboxy-terminal 60-kDaapp frag-
ment. Cleavage of carboxylase that had been labeled in the 
presence of increasing proFIX/PT28 showed that protection 
from [125I]CP2 labeling was the same for the 30 and 60-kDaapp 
fragments (data not shown). 
As a first step toward identifying the [125I]CP2 crosslinking 
sites, we developed a preparative technique for purifying the 
labeled 30 and 60-kDaapp fragments. Following photolabeling 
and trypsinization, phospholipid and other contaminants were 
separated from the carboxylase by S-300 size exclusion chro-
matography in the presence of SDS. After concentration the 
SDS solubilized carboxylase was initially run on a non-reduc-
ing preparative SDS gel. Gel slices containing the trypsin 
cleaved but disulfide-linked 30 and 60-kDaapp fragments 
were cut out, equilibrated with DTT containing sample buffer 
and run under reducing conditions on a second preparative 
gel. The now separated 30 and 60-kDaapp fragments were cut 
out of the gel and subjected to proteolysis either 'in gel' or 
after elution into dialysis tubing. 
Both the 30 and 60-kDaapp fragments were used in attempts 
to obtain smaller fragments of the carboxylase that still re-
tained the [125I]CP2 peptide label. Unfortunately, various 
problems prevented more localized identification of the cross-
linking sites. The 30-kDaapp fragment, which contains the 
major crosslinking site(s), was found to be resistant to further 
proteolytic cleavage. This domain was resistant to cleavage 
even by the non-specific protease, proteinase K, however at 
concentrations 10-fold higher than required to digest other 
proteins, proteinase K did generate an incompletely digested 
smear of fragments unsuitable for sequencing (data not 
shown). 
The 60-kDaapp fragment which contains the minor cross-
linking site was effectively cleaved by endo Glu-C into a fam-
ily of discrete fragments (Fig. 5) including relatively stable 10 
and 34-kDaapp fragments. Unfortunately, we have been un-
able to identify the fragment sequence at the crosslinking site 
despite repeated attempts. The difficulty was mainly due to the 
small quantity of protein available. 
In the process of localizing the crosslinking sites, the puri-
fied 60-kDaapp fragment was sequenced following transfer to 
an Immobilon PVDF membrane. This analysis showed that 
the amino terminus of the carboxy-terminal 60-kDaapp frag-
ment is either R350 or R352 of the 758 amino acid y-glutamyl 
carboxylase. Thus the amino-terminal 30-kDaapp fragment has 
an actual protein molecular mass of 39 kDa and the carboxy-
terminal 60-kDaapp fragment has a protein molecular mass of 
48 kDa. 
4. Discussion 
We designed the probe, [125I]CP2, to label the catalytic site 
of the y-glutamyl carboxylase by placing the photoprobe, Bpa, 
at position +4 near the carboxylatable glutamate residues 
(positions +6 and +7). Placement of the photoprobe in this 
position did not significantly decrease carboxylation com-
pared to proFIX/PT28, indicating that the carboxylatable glu-
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Fig. 5. Endo Glu-C digestion of the [125I]CP2 crosslinked 60-kDaapp 
trypsin fragment. The 60-kDaapp trypsin fragment (~1000 cpm) 
was digested 'in gel' with 2.5 ng (lane 2), 50 ng (lane 4) and 1000 ng 
(lane 6) of endo Glu-C. Lanes 1, 3, 5 and 7 contain iodinated 
molecular weight markers of the indicated mass. 
tamate residues were still associating with the catalytic site. 
Irreversible UV crosslinking of [125I]CP2 to the carboxylase at 
different probe concentrations, was saturable, which is consis-
tent with the peptide association at the carboxylase propeptide 
binding site. In further support of specific active site cross-
linking, photolabelling by our affinity ligand approached 90% 
after a 15 min irradition, resulting in the incorporation of 
about 1 [125I]CP2 per carboxylase. In total, these observations 
indicate that the carboxylatable glutamate residues could as-
sociate with the catalytic active site and bring the photoprobe 
into close proximity to the active site. Interestingly, [125I]CP2 
labeled both an amino-terminal 30-kDaapp and a carboxy-ter-
minal 60-kDaapp trypsin fragment. Both of these associations 
were very likely specific, since the competitor proFIX/PT28 
(10 (j,M) blocked labeling of each fragment with equal effi-
ciency. 
In order to interpret this observation, we localized the tryp-
sin cleavage site by sequencing the 60-kDaapp fragment. Un-
expectedly, the amino terminus of this fragment was found to 
be at either R350 or R352 indicating that the carboxy-termi-
nal 60-kDaapp fragment had an actual protein molecular mass 
of 48 kDa. This cleavage location also shows that the amino-
terminal 30-kDaapp fragment has an actual protein molecular 
mass of 39 kDa. The 30-kDaapp fragment includes the amino-
terminal hydrophobic domain and 60-kDaapp fragment con-
tains most of the carboxy-terminal hydrophilic domain (Fig. 
6). The fact that [125I]CP2 labeled both fragments suggests 
that the active site region includes portions of both domains. 
The anomalous migration of the 30-kDaapp fragment may 
explain the discrepancy between the observations of Wu et al. 
[19] and Yamada et al. [18] who tentatively localized the pro-
Hydrophobic 
Domain 
t t i t 
0 225 300 350 
352 
Fig. 6. Schematic representation of the vitamin K-dependent carboxy 
gested [10] are indicated by the filled areas. The trypsin cleavage site 
R350/R352 and E518) are indicated. 
peptide binding site, respectively, in the carboxy-terminal hy-
drophilic and amino-terminal hydrophobic domains of the 
carboxylase. In their effort to localize this propeptide recog-
nition site Yamada et al. used [125I]tyrosyl-proFIX19 analogs 
containing the photoprobe Bpa [18]. The binding sites for two 
of these probes were localized to amino-terminal 30 and 33-
kDaapp endo Glu-C fragments. Based on mass estimation 
from SDS-PAGE these cleavage sites were suggested to be 
near residue 225 (Fig. 6). However, these amino-terminal 30 
and 33-kDaapp endo Glu-C fragments probably display the 
highly anomalous SDS-PAGE migration observed for the 
amino-terminal 30-kDaapp trypsin fragment (actual mass 
39 kDa). Thus, it is likely that these endo Glu-C fragments 
are cleaved near the trypsin site (R350/352) in the carboxy 
terminal hydrophilic domain. This is made more likely by 
the fact that there are no cleavage sites between amino acids 
249 and 313 at the end of the hydrophobic region. Because the 
[125I]tyrosyl-proFIX19 crosslinking sites on the endo Glu-C 
fragments were localized very near the cleavage sites [18], 
these crosslinking sites are probably in the carboxy-terminal 
hydrophilic domain. 
The original localization of the propeptide binding site 
within the amino terminal 225 amino acids of the carboxylase 
also did not agree well with the mutagenesis studies [18,12]. Of 
the three mutated patches that resulted in reduced carboxylase 
activity apparently because of poor propeptide binding, two 
were at residues 406/408 and 513/515 [12]. 
For reasons that are unclear, we could not precisely localize 
the [125I]CP2 crosslinking site in the carboxy-terminal hydro-
philic domain. However, endo Glu-C cleavage of the 
60-kDaapp trypsin fragment releases a relatively stable labeled 
34-kDaapp fragment. The stability of this fragment suggests 
the [125I]CP2 crosslinking site is between residues 350 and 
518 (Fig. 6), a span which includes only 4 cleavage sites, 
rather than between residues 518 and 758, a span which in-
cludes 28 cleavage sites. Although [125I]CP2 was designed to 
label the catalytic active site, it is possible that crosslinking in 
the carboxy-terminal hydrophilic domain represents crosslink-
ing at the propeptide binding site given the proximity of the 
photoprobe (Bpa, position +4) to the propeptide (—18 to —1). 
In total, the available evidence [18-20] suggests that a signifi-
cant portion of the propeptide recognition site resides within 
the carboxy-terminal hydrophilic domain. 
The fact that the Bpa residue in [125I]CP2 is near the first 
diglutamate pair and that most of the labeling was associated 
with the hydrophobic amino terminal trypsin fragment is con-
sistent with a catalytic active site that may be mostly located 
within this domain. This would agree with the assigned loca-
tion for the [125I]tyrosyl-Af-(bromoacetyl)-FLEELY binding 
Hydrophilic 
Domain 
t I 
518 758 Residue 
lase sequence. The three putative transmembrane domains originally sug-
(R350/R352) and likely [125I]CP2 crosslinking location (between residues 
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site [17]. The presence of a port ion of the catalytic site within 
the hydrophobic domain is also suggested by mutagenesis ex-
periments which showed that neutralization of the charged 
patch at residues 217/218 resulted in a mutant with no activity 
[12]. These results suggest that at least a port ion of the cata-
lytic active site resides in the hydrophobic domain. 
In light of the anomalous migration of the amino terminal 
hydrophobic domain, the available evidence suggests that a 
significant port ion of the propeptide recognition site resides in 
the hydrophilic domain probably in residues near the centre of 
the carboxylase. The fact that [125I]CP2, designed to crosslink 
near the catalytic active site was associated with both the 
amino and carboxy-terminal trypsin fragments suggests the 
active site region includes elements of both the hydrophobic 
and hydrophilic domains. 
References 
[1] Wright, D.J., Morris, D.P. and Stafford, D.W. (1995) in: Molec-
ular Basis of Thrombosis and Hemostasis (High, K.A., and Ro-
berts, H.R., Eds.), pp. 309-329, Marcel Dekker, Inc., New York. 
[2] Suttie, J.W. (1993) FASEB J. 7, 445^152. 
[3] Suttie, J.M. (1988) Biofactors 1, 55-60. 
[4] Price, P.A. (1988) Annu. Rev. Nutr. 8, 565. 
[5] Suttie, J.W. (1985) Annu. Rev. Biochem. 54, 459-477. 
[6] Pan, L.C. and Price, P.A. (1985) Proc. Natl. Acad. Sci. U.S.A. 
82, 6109-6113. 
[7] Jorgensen, M.J., Cantor, A.B., Furie, B.C., Brown, C.L., Shoe-
maker, C.B. and Furie, B. (1987) Cell 48, 185-191. 
[8] Foster, D.C., Rudinski, M.S., Schach, B.G., Berkner, K.L., Ku-
mar, A.A., Hagen, F.S., Sprechner, C.A., Insley, M.Y. and Da-
vie, E.W. (1987) Biochemistry 26, 7003-7011. 
[9] Wu, S.-M., Morris, D.P. and Stafford, D.W. (1991) Proc. Natl. 
Acad. Sci. U.S.A. 88, 2236-2240. 
[10] Wu, S.-M., Cheung, W.F., Frazier, D.F. and Stafford, D.W. 
(1991) Science 254, 1634-1636. 
[11 
[12 
[13: 
[14] 
[is: 
tie: 
[17 
[is: 
[is: 
[20 
[21 
[22 
[23: 
P4: 
[25 
[26 
[27 
[28" 
[29 
Roth, D.A., Rehemtulla, A., Kaufman, R.J., Walsh, C.T., Furie, 
B. and Furie, B.C. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 8372-
8376. 
Sugiura, I., Furie, B., Walsh, C.T. and Furie, B.C. (1996) J. Biol. 
Chem. 271, 17837-17844. 
Dubois, J., Gaudry, M., Bory, S., Azerad, R. and Marquet, A. 
(1983) J. Biol. Chem. 258, 7897. 
Decottignies-Le Marechal, P., Ducrocq, C , Marquet, A. and 
Azerad, R. (1984) J. Biol. Chem. 259, 15010. 
Vidal-Cros, A., Gaudry, M. and Marquet, A. (1990) Biochem. J. 
260, 749. 
Dubois, J., Dugave, C , Bory, S., Gaudry, M. and Marquet, A. 
(1991) Biochemistry 30, 10506. 
Kuliopulos, A., Nelson, N.P., Yamada, M., Walsh, C.T., Furie, 
B., Furie, B.C. and Roth, D.A. (1994) J. Biol. Chem. 269, 21364-
21370. 
Yamada, M., Kuliopulos, A., Nelson, N.P., Roth, D.A., Furie, 
B., Furie, B.C. and Walsh, C.T. (1995) Biochemistry 34, 481-
489. 
Wu, S.-M., Morris, D.P. and Stafford, D.W. Enzymes: Mecha-
nisms of Action III A1414, 904. 
Wright, D.J., Morris, D.P. and Stafford, D.W. (1995) in: Molec-
ular Basis of Thrombosis and Hemostasis (High, K.A., and Ro-
berts, H.R., Eds.), pp. 323-324, Marcel Dekker, Inc., New York. 
Hubbard, B., Jacobs, M., Ulrich, M., Walsh, C.T., Furie, B. and 
Furie, B.C. (1989) J. Biol. Chem. 264, 14145-14150. 
Kauer, J.C., Erickson-Viitnamin, S., Wolfe, H.R. and Degrado 
Jr., W.F. (1986) J. Biol. Chem. 261, 10695-10700. 
Josien, H., Martin, A. and Chassaing, G. (1991) Tetrahedron 
Lett. 32, 6547-6550. 
Josien, H. and Chassaing, G. (1992) Tetrahedron Asym. 3, 1351— 
1354. 
Merrifield, R.B. (1963) J. Am. Chem. Soc. 85, 2149-2154. 
Heald, S.L., Jeffs, P.W., Lavin, T.N., Nambi, P., Lefkowitz, R.J. 
and Caron, M.G. (1983) J. Med. Chem. 26, 832-838. 
Morris, D.P., Soute, B.A.M., Vermeer, C. and Stafford, D.W. 
(1993) J. Biol. Chem. 268, 8735-8742. 
Laemmli, U.K. (1970) Nature 227, 1940. 
Suttie, J.W., Hageman, J.M., Lehrman, S.R. and Rich, D.H. 
(1976) J. Biol. Chem. 251, 5827-5830. 
